628 related articles for article (PubMed ID: 15477430)
21. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
22. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
Tanis BC; Rosendaal FR
Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
[TBL] [Abstract][Full Text] [Related]
23. The truth about oral contraceptives and venous thromboembolism.
Shulman LP; Goldzieher JW
J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
[TBL] [Abstract][Full Text] [Related]
24. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis.
Saadatnia M; Tajmirriahi M
Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938
[TBL] [Abstract][Full Text] [Related]
25. [Oral contraception and hormone replacement therapy: management of their thromboembolic risk in the perioperative period].
Chalhoub V; Edelman P; Staiti G; Benhamou D
Ann Fr Anesth Reanim; 2008 May; 27(5):405-15. PubMed ID: 18472389
[TBL] [Abstract][Full Text] [Related]
26. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of hormonal contraceptives-related venous thromboembolism.
Hugon-Rodin J; Gompel A; Plu-Bureau G
Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
[TBL] [Abstract][Full Text] [Related]
28. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
29. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
van den Brûle F; Gaspard U
J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
[TBL] [Abstract][Full Text] [Related]
30. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism in women: a specific reproductive health risk.
ESHRE Capri Workshop Group
Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
[TBL] [Abstract][Full Text] [Related]
32. Prevention and treatment of hormone-associated venous thromboembolism: a patient management approach.
Ueng J; Douketis JD
Hematol Oncol Clin North Am; 2010 Aug; 24(4):683-94, vii-viii. PubMed ID: 20659653
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
34. [The vascular risk of third generation contraceptive pills].
Levesque H; Borg JY; Courtois H
J Mal Vasc; 1997 Mar; 22(1):5-12. PubMed ID: 9120373
[TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism associated with pregnancy and hormonal therapy.
Jacobsen AF; Sandset PM
Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hormone therapy and the risk of venous thromboembolism.
Rachoń D; Teede H
Climacteric; 2008 Aug; 11(4):273-9. PubMed ID: 18645692
[TBL] [Abstract][Full Text] [Related]
37. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
[TBL] [Abstract][Full Text] [Related]
38. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
[TBL] [Abstract][Full Text] [Related]
39. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
[TBL] [Abstract][Full Text] [Related]
40. Oral contraception and thrombophilia.
Blickstein D; Blickstein I
Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
